A Randomized Controlled Clinical Trial of Lifestyle Intervention and Pioglitazone for Normalization of Glucose Status in Chinese with Prediabetes

AIMS: Prediabetes has been proved as an important risk factor of both diabetes and cardiovascular disease (CVD). Previous studies have shown that both lifestyle intervention and pioglitazone may delay the development of diabetes in patients with prediabetes. However, no study has ever explored wheth...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yingying, Wang, Hongyuan, Zhou, Xianghai, Chang, Cuiqing, Chen, Wei, Guo, Xiaohui, Yang, Jinkui, Ji, Linong, Paul, Sanjoy K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759441/
https://www.ncbi.nlm.nih.gov/pubmed/35036447
http://dx.doi.org/10.1155/2022/2971382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759441/
https://www.ncbi.nlm.nih.gov/pubmed/35036447
http://dx.doi.org/10.1155/2022/2971382

Ejemplares similares